Patents Assigned to Angiogenesis Technologies, Inc.
  • Anti-angiogenic Compositions and methods for the treatment of arthritis
    Patent number: 5994341
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 30, 1999
    Assignee: Angiogenesis Technologies, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault
  • Anti-angiogenic compositions and methods of use
    Patent number: 5716981
    Abstract: The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 10, 1998
    Assignee: Angiogenesis Technologies, Inc.
    Inventors: William L. Hunter, Lindsay S. Machan, A. Larry Arsenault